Novel insights into SGLT2 inhibitor efficacy in heart failure: A meta-analysis employing win ratio, hazard ratio, and risk ratio

Authors

Institutions

Publication Details

Journal
American Heart Journal Plus Cardiology Research and Practice
Published
2026-01-22
DOI
https://doi.org/10.1016/j.ahjo.2026.100718
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Novel insights into SGLT2 inhibitor efficacy in heart failure: A meta-analysis employing win ratio, hazard ratio, and risk ratio

Ali Nasrollahizadeh, Amir Nasrollahizadeh, Soheil Rahmati, Daniel Modin et al.
American Heart Journal Plus Cardiology Research and Practice
Diabetes Treatment and Management
article

Novel insights into SGLT2 inhibitor efficacy in heart failure: A meta-analysis employing win ratio, hazard ratio, and risk ratio

Ali Nasrollahizadeh, Amir Nasrollahizadeh, Soheil Rahmati, Daniel Modin, Diaa Hakim, Niklas Dyrby Johansen, Sepide Javankiani, Kaveh Hosseini, Tor Biering-Sørensen
article en

Abstract

No abstract available for this paper.
American Heart Journal Plus Cardiology Research and PracticeVol. 63
University of Copenhagen (DK), Brigham and Women's Hospital (US), Steno Diabetes Centers (DK), Copenhagen University Hospital (DK), Gentofte Hospital (DK), Rigshospitalet (DK), Tehran University of Medical Sciences (IR)
Openalex Percentile: Top 82%
Diabetes Treatment and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.